These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 35868124)

  • 1. Scaffold modified Vemurafenib analogues as highly selective mitogen activated protein kinase kinase 4 (MKK4) inhibitors.
    Juchum M; Pfaffenrot B; Klövekorn P; Selig R; Albrecht W; Zender L; Laufer SA
    Eur J Med Chem; 2022 Oct; 240():114584. PubMed ID: 35868124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From off-to on-target: New BRAF-inhibitor-template-derived compounds selectively targeting mitogen activated protein kinase kinase 4 (MKK4).
    Klövekorn P; Pfaffenrot B; Juchum M; Selig R; Albrecht W; Zender L; Laufer SA
    Eur J Med Chem; 2021 Jan; 210():112963. PubMed ID: 33199152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of 1H-pyrazolo[3,4-b]pyridines targeting mitogen-activated protein kinase kinase 4 (MKK4) - A promising target for liver regeneration.
    Pfaffenrot B; Klövekorn P; Juchum M; Selig R; Albrecht W; Zender L; Laufer SA
    Eur J Med Chem; 2021 Jun; 218():113371. PubMed ID: 33794385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of novel fluorescently labeled analogs of vemurafenib targeting MKK4.
    Kircher T; Pantsar T; Oder A; Peter von Kries J; Juchum M; Pfaffenrot B; Kloevekorn P; Albrecht W; Selig R; Laufer S
    Eur J Med Chem; 2021 Jan; 209():112901. PubMed ID: 33092905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Direct in vivo RNAi screen identifies MKK4 as a key regulator of liver regeneration.
    Wuestefeld T; Pesic M; Rudalska R; Dauch D; Longerich T; Kang TW; Yevsa T; Heinzmann F; Hoenicke L; Hohmeyer A; Potapova A; Rittelmeier I; Jarek M; Geffers R; Scharfe M; Klawonn F; Schirmacher P; Malek NP; Ott M; Nordheim A; Vogel A; Manns MP; Zender L
    Cell; 2013 Apr; 153(2):389-401. PubMed ID: 23582328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine A(2a) receptor stimulation prevents hepatocyte lipotoxicity and non-alcoholic steatohepatitis (NASH) in rats.
    Imarisio C; Alchera E; Sutti S; Valente G; Boccafoschi F; Albano E; Carini R
    Clin Sci (Lond); 2012 Sep; 123(5):323-32. PubMed ID: 22439844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-in-class MKK4 inhibitors enhance liver regeneration and prevent liver failure.
    Zwirner S; Abu Rmilah AA; Klotz S; Pfaffenroth B; Kloevekorn P; Moschopoulou AA; Schuette S; Haag M; Selig R; Li K; Zhou W; Nelson E; Poso A; Chen H; Amiot B; Jia Y; Minshew A; Michalak G; Cui W; Rist E; Longerich T; Jung B; Felgendreff P; Trompak O; Premsrirut PK; Gries K; Muerdter TE; Heinkele G; Wuestefeld T; Shapiro D; Weissbach M; Koenigsrainer A; Sipos B; Ab E; Zacarias MO; Theisgen S; Gruenheit N; Biskup S; Schwab M; Albrecht W; Laufer S; Nyberg S; Zender L
    Cell; 2024 Mar; 187(7):1666-1684.e26. PubMed ID: 38490194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Protoberberine derivative HWY336 selectively inhibits MKK4 and MKK7 in mammalian cells: the importance of activation loop on selectivity.
    Kim N; Park J; Gadhe CG; Cho SJ; Oh Y; Kim D; Song K
    PLoS One; 2014; 9(4):e91037. PubMed ID: 24759688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of JNK3 alpha 1 requires both MKK4 and MKK7: kinetic characterization of in vitro phosphorylated JNK3 alpha 1.
    Lisnock J; Griffin P; Calaycay J; Frantz B; Parsons J; O'Keefe SJ; LoGrasso P
    Biochemistry; 2000 Mar; 39(11):3141-8. PubMed ID: 10715136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of mitogen-activated protein kinase kinase 4 (MKK4) and 7 (MKK7) by signaling from G protein beta gamma subunit in human embryonal kidney 293 cells.
    Yamauchi J; Kaziro Y; Itoh H
    J Biol Chem; 1999 Jan; 274(4):1957-65. PubMed ID: 9890951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of mitogen-activated protein kinase kinase 4 in cancer.
    Whitmarsh AJ; Davis RJ
    Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of the MKK4 gene causes embryonic death, inhibition of c-Jun NH2-terminal kinase activation, and defects in AP-1 transcriptional activity.
    Yang D; Tournier C; Wysk M; Lu HT; Xu J; Davis RJ; Flavell RA
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3004-9. PubMed ID: 9096336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
    Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
    Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of Covalent MKK4/7 Dual Inhibitor.
    Jiang J; Jiang B; He Z; Ficarro SB; Che J; Marto JA; Gao Y; Zhang T; Gray NS
    Cell Chem Biol; 2020 Dec; 27(12):1553-1560.e8. PubMed ID: 32916088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filamin associates with stress signalling kinases MKK7 and MKK4 and regulates JNK activation.
    Nakagawa K; Sugahara M; Yamasaki T; Kajiho H; Takahashi S; Hirayama J; Minami Y; Ohta Y; Watanabe T; Hata Y; Katada T; Nishina H
    Biochem J; 2010 Mar; 427(2):237-45. PubMed ID: 20156194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
    Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
    Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-activated protein kinase kinase 4 (MKK4).
    Cuenda A
    Int J Biochem Cell Biol; 2000 Jun; 32(6):581-7. PubMed ID: 10785355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
    Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
    Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun NH2-terminal kinase activating kinase 1/mitogen-activated protein kinase kinase 4-mediated inhibition of SKOV3ip.1 ovarian cancer metastasis involves growth arrest and p21 up-regulation.
    Lotan T; Hickson J; Souris J; Huo D; Taylor J; Li T; Otto K; Yamada SD; Macleod K; Rinker-Schaeffer CW
    Cancer Res; 2008 Apr; 68(7):2166-75. PubMed ID: 18381422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of MAP2 kinases and p38 kinase in acute murine liver injury models.
    Zhang J; Min RWM; Le K; Zhou S; Aghajan M; Than TA; Win S; Kaplowitz N
    Cell Death Dis; 2017 Jun; 8(6):e2903. PubMed ID: 28661486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.